Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 5
1999 7
2000 2
2001 1
2002 5
2003 10
2004 6
2005 3
2006 4
2007 10
2008 12
2009 23
2010 33
2011 29
2012 38
2013 44
2014 50
2015 50
2016 49
2017 56
2018 45
2019 54
2020 43
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22976236

515 results
Results by year
Filters applied: . Clear all
Page 1
Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.
Desikan RS, McEvoy LK, Holland D, Thompson WK, Brewer JB, Aisen PS, Andreassen OA, Hyman BT, Sperling RA, Dale AM; Alzheimer's Disease Neuroimaging Initiative. Desikan RS, et al. AJNR Am J Neuroradiol. 2013 Mar;34(3):505-10. doi: 10.3174/ajnr.A3267. Epub 2012 Sep 13. AJNR Am J Neuroradiol. 2013. PMID: 22976236 Free PMC article.
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.
Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Tosun D, et al. Neurobiol Aging. 2010 Aug;31(8):1340-54. doi: 10.1016/j.neurobiolaging.2010.04.030. Epub 2010 Jun 8. Neurobiol Aging. 2010. PMID: 20570401 Free PMC article. Clinical Trial.
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative. Lautner R, et al. JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease.
Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative. Vemuri P, et al. Ann Neurol. 2010 Mar;67(3):308-16. doi: 10.1002/ana.21953. Ann Neurol. 2010. PMID: 20373342 Free PMC article.
The role of clusterin in amyloid-β-associated neurodegeneration.
Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM; Alzheimer’s Disease Neuroimaging Initiative Group. Desikan RS, et al. JAMA Neurol. 2014 Feb;71(2):180-7. doi: 10.1001/jamaneurol.2013.4560. JAMA Neurol. 2014. PMID: 24378367 Free PMC article. Clinical Trial.
Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM. Sunderland T, et al. Biol Psychiatry. 2004 Nov 1;56(9):670-6. doi: 10.1016/j.biopsych.2004.07.021. Biol Psychiatry. 2004. PMID: 15522251
APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ. Cysique LA, et al. BMC Neurol. 2015 Apr 1;15:51. doi: 10.1186/s12883-015-0298-0. BMC Neurol. 2015. PMID: 25880550 Free PMC article. Clinical Trial.
Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y, Tan L, Wang HF, Liu Y, Hao XK, Tan CC, Jiang T, Liu B, Zhang DQ, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. Liu Y, et al. Mol Neurobiol. 2016 Sep;53(7):4539-47. doi: 10.1007/s12035-015-9388-7. Epub 2015 Aug 23. Mol Neurobiol. 2016. PMID: 26298664
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA, Pua EP, Zhou J; Alzheimer’s Disease Neuroimaging Initiative. Susanto TA, et al. J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451. J Alzheimers Dis. 2015. PMID: 25524955
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer's disease.
Bonham LW, Desikan RS, Yokoyama JS; Alzheimer’s Disease Neuroimaging Initiative. Bonham LW, et al. Acta Neuropathol Commun. 2016 Jun 29;4(1):65. doi: 10.1186/s40478-016-0339-y. Acta Neuropathol Commun. 2016. PMID: 27357286 Free PMC article.
515 results
Jump to page